SeaStar Medical Holding Corporation (ICU) Insider Trading Activity

NASDAQ$2.0415+0.04 (2.00%)
Market Cap
$5.68M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
362 of 849
Rank in Industry
211 of 491

ICU Insider Trading Activity

ICU Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$8,538
3
100
Sells
$0
0
0

Related Transactions

Messinger MichaelChief Financial Officer
2
$7,551
0
$0
$7,551
Baird Jennifer Adirector
1
$987
0
$0
$987

About SeaStar Medical Holding Corporation

SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the immune 'effector cells' responsible for driving systemic inflammation, a process that directly harms tissues and releases a cascade of pro-inflammatory cytokines, thereby initiating and perpetuating dysregulated immune reactions. …

Insider Activity of SeaStar Medical Holding Corporation

Over the last 12 months, insiders at SeaStar Medical Holding Corporation have bought $8,538 and sold $0 worth of SeaStar Medical Holding Corporation stock.

On average, over the past 5 years, insiders at SeaStar Medical Holding Corporation have bought $60,642 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Messinger Michael (Chief Financial Officer) — $7,551. Baird Jennifer A (director) — $987.

The last purchase of 750 shares for transaction amount of $2,453 was made by Messinger Michael (Chief Financial Officer) on 2026‑08‑18.

List of Insider Buy and Sell Transactions, SeaStar Medical Holding Corporation

2026-08-18PurchaseMessinger MichaelChief Financial Officer
750
0.0259%
$3.27
$2,453
-6.44%
2025-12-19PurchaseBaird Jennifer Adirector
4,200
0.0147%
$0.24
$987
+27.76%
2025-12-09PurchaseMessinger MichaelChief Financial Officer
14,500
0.0513%
$0.35
$5,098
-12.08%
2025-08-27PurchaseVan Heel Kennethdirector
10,000
0.0362%
$0.86
$8,565
-58.37%
2025-08-26PurchaseVan Heel Kennethdirector
25,000
0.0996%
$0.89
$22,248
-60.51%
2025-08-22PurchaseChung KevinChief Medical Officer
10,000
0.0358%
$0.80
$8,000
-55.44%
2025-06-30PurchaseBaird Jennifer Adirector
10,000
0.0608%
$0.42
$4,174
-8.69%
2025-06-24PurchaseNeuman Johndirector
40,000
0.3573%
$0.36
$14,396
+10.28%
2025-05-20PurchaseChung KevinChief Medical Officer
4,500
0.0414%
$1.25
$5,625
-65.74%
2025-05-20PurchaseBaird Jennifer Adirector
10,000
0.0944%
$1.28
$12,815
-65.74%
2024-12-11PurchaseNeuman Johndirector
10,000
0.2126%
$2.04
$20,405
-44.26%
2024-11-18PurchaseChung KevinChief Medical Officer
4,250
0.0842%
$1.99
$8,458
-44.89%
2024-09-30PurchaseChung KevinChief Medical Officer
1,000
0.025%
$4.26
$4,258
-66.08%
2024-08-15PurchaseNeuman Johndirector
10,000
0.1724%
$5.24
$52,396
-70.23%
2024-06-17PurchaseNeuman Johndirector
10,000
0.3451%
$4.35
$43,521
-44.49%
2024-06-14PurchaseNeuman Johndirector
10,000
0.2927%
$3.69
$36,905
-43.38%
2023-11-22PurchaseVan Heel Kennethdirector
100,000
0.5274%
$0.40
$40,000
-2.62%
2023-05-30PurchaseChung KevinChief Medical Officer
12,543
0.17%
$0.47
$5,953
-1.66%
2022-04-05PurchaseChung KevinChief Medical Officer
3,760
0.1986%
$1.85
$6,956
+4209.11%
Total: 19
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Baird Jennifer Adirector
36200
1.2756%
$72,400.0030
<0.0001%
Messinger MichaelChief Financial Officer
2500
0.0881%
$5,000.0020
Neuman Johndirector
80000
2.8189%
$160,000.0050
<0.0001%
Chung KevinChief Medical Officer
58184
2.0502%
$116,368.0060
<0.0001%
Van Heel Kennethdirector
49400
1.7407%
$98,800.0030
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$6,974,678
45
-14.98%
$4.63M
$13,664,154
40
-70.35%
$7.05M
$29,645,465
28
8.09%
$6.48M
$63,749,694
24
-12.24%
$6.4M
SeaStar Medical Holding Corporation
(ICU)
$287,718
15
-41.45%
$5.68M

ICU Institutional Investors: Active Positions

Increased Positions8+25.81%21,651+19.79%
Decreased Positions10-32.26%51,097-46.7%
New Positions<1New12,695New
Sold Out Positions9Sold Out51,037Sold Out
Total Postitions29-6.45%79,958-26.91%

ICU Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$99.00<0.01%377,377+319,879+556.33%2025-09-30
Geode Capital Management, Llc$68.00<0.01%258,922+190,094+276.19%2025-09-30
Millennium Management Llc$47.00<0.01%179,673+179,673New2025-09-30
Trinity Financial Advisors Llc$13.00<0.01%50,000+35,000+233.33%2025-09-30
Xtx Topco Ltd$13.00<0.01%48,558-12,425-20.38%2025-09-30
Dynamic Advisor Solutions Llc$8.00<0.01%29,278+29,278New2025-09-30
Toronto Dominion Bank$7.00<0.01%25,000+25,000New2025-09-30
Goldman Sachs Group Inc$5.00<0.01%18,986+6,562+52.82%2025-09-30
Raymond James Financial Inc$5.00<0.01%17,714-19,547-52.46%2025-09-30
Tyche Wealth Partners Llc$5.00<0.01%17,700-20,000-53.05%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.